ATC Group: J07BA03 Encephalitis, Japanese, live attenuated

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of J07BA03 in the ATC hierarchy

Level Code Title
1 J Antiinfectives for systemic use
2 J07 Vaccines
3 J07B Viral vaccines
4 J07BA Encephalitis vaccines
5 J07BA03

Active ingredients in J07BA03

Active Ingredient Description
Japanese encephalitis, live attenuated

Japanese encephalitis is a disease caused by the mosquito-borne Japanese encephalitis virus (JEV). Japanese Encephalitis Vaccine acts by inducing antibodies that neutralize live JEV.

Medicines in this ATC group

Hong Kong (HK)

Singapore (SG)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.